17-80188410-A-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001366385.1(CARD14):c.709A>G(p.Asn237Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N237H) has been classified as Benign.
Frequency
Consequence
NM_001366385.1 missense
Scores
Clinical Significance
Conservation
Publications
- familial pityriasis rubra pilarisInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
- psoriasis 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CARD14 | NM_001366385.1 | c.709A>G | p.Asn237Asp | missense_variant | Exon 8 of 24 | ENST00000648509.2 | NP_001353314.1 | 
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF:  0.00  AC: 0AN: 1458684Hom.:  0  Cov.: 31 AF XY:  0.00  AC XY: 0AN XY: 725568 
GnomAD4 genome  
ClinVar
Submissions by phenotype
Pityriasis rubra pilaris;C1864497:Psoriasis 2    Uncertain:1 
This sequence change replaces asparagine, which is neutral and polar, with aspartic acid, which is acidic and polar, at codon 237 of the CARD14 protein (p.Asn237Asp). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CARD14-related conditions. Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt CARD14 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at